Theresa Wingrove is SVP OF REGULATORY AFFAIRS of ImmunoGen, Inc.. Currently has a direct ownership of 0 shares of IMGN, which is worth approximately $0. The most recent transaction as insider was on Feb 12, 2024, when has been sold 21,039 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Theresa Wingrove Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 12 2024
SELL
Sale (or disposition) back to the issuer
-
21,039 Reduced 100.0%
0 Common Stock
Feb 05 2024
SELL
Open market or private sale
$352,391 $29.3 p/Share
12,027 Reduced 36.37%
21,039 Common Stock
Feb 02 2024
BUY
Exercise of conversion of derivative security
-
29,640 Added 47.27%
33,066 Common Stock
Jan 16 2024
SELL
Open market or private sale
$5,562,449 $29.64 p/Share
187,667 Reduced 98.21%
3,426 Common Stock
Jan 16 2024
BUY
Exercise of conversion of derivative security
$990,881 $5.28 p/Share
187,667 Added 49.55%
191,093 Common Stock
Dec 29 2023
BUY
Grant, award, or other acquisition
$9,846 $16.01 p/Share
615 Added 15.22%
3,426 Common Stock
Dec 15 2023
SELL
Open market or private sale
$3,452,883 $29.4 p/Share
117,445 Reduced 97.66%
2,811 Common Stock
Dec 15 2023
BUY
Exercise of conversion of derivative security
$580,178 $4.94 p/Share
117,445 Added 49.41%
120,256 Common Stock
Nov 30 2023
SELL
Open market or private sale
$4,760,074 $28.95 p/Share
164,424 Reduced 98.32%
2,811 Common Stock
Nov 30 2023
BUY
Exercise of conversion of derivative security
$1,762,625 $10.72 p/Share
164,424 Added 49.58%
167,235 Common Stock
Nov 29 2023
SELL
Open market or private sale
$113,154 $16.66 p/Share
6,792 Reduced 70.73%
2,811 Common Stock
Nov 29 2023
BUY
Exercise of conversion of derivative security
$72,334 $10.65 p/Share
6,792 Added 41.43%
9,603 Common Stock
Nov 15 2023
SELL
Open market or private sale
$2,642,591 $15.85 p/Share
166,725 Reduced 98.34%
2,811 Common Stock
Nov 15 2023
BUY
Exercise of conversion of derivative security
$758,598 $4.55 p/Share
166,725 Added 49.58%
169,536 Common Stock
Nov 07 2023
SELL
Open market or private sale
$325,153 $16.66 p/Share
19,517 Reduced 87.41%
2,811 Common Stock
Nov 07 2023
BUY
Exercise of conversion of derivative security
$207,856 $10.65 p/Share
19,517 Added 46.64%
22,328 Common Stock
Oct 16 2023
SELL
Open market or private sale
$2,764,857 $14.4 p/Share
192,004 Reduced 98.56%
2,811 Common Stock
Oct 16 2023
BUY
Exercise of conversion of derivative security
$873,618 $4.55 p/Share
192,004 Added 49.64%
194,815 Common Stock
Sep 15 2023
SELL
Open market or private sale
$2,964,680 $15.44 p/Share
192,013 Reduced 98.56%
2,811 Common Stock
Sep 15 2023
BUY
Exercise of conversion of derivative security
$372,731 $3.43 p/Share
108,668 Added 35.81%
194,824 Common Stock
Jun 30 2023
BUY
Grant, award, or other acquisition
$11,384 $4.05 p/Share
2,811 Added 3.16%
86,156 Common Stock
Dec 30 2022
BUY
Grant, award, or other acquisition
$4,433 $3.92 p/Share
1,131 Added 1.34%
83,345 Common Stock
Jun 30 2022
BUY
Grant, award, or other acquisition
$10,130 $3.83 p/Share
2,645 Added 3.12%
82,214 Common Stock
Dec 31 2021
BUY
Grant, award, or other acquisition
$11,486 $5.6 p/Share
2,051 Added 2.51%
79,569 Common Stock
Jun 30 2021
BUY
Grant, award, or other acquisition
$9,759 $5.52 p/Share
1,768 Added 2.23%
77,518 Common Stock
TW

Theresa Wingrove

SVP OF REGULATORY AFFAIRS
Waltham, MA

Track Institutional and Insider Activities on IMGN

Follow ImmunoGen, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMGN shares.

Notify only if

Insider Trading

Get notified when an Immuno Gen, Inc. insider buys or sells IMGN shares.

Notify only if

News

Receive news related to ImmunoGen, Inc.

Track Activities on IMGN